David MNV, Shetty M. Digoxin. StatPearls Publishing; 2021. 18 July 2021. https://www.ncbi.nlm.nih.gov/books/NBK556025/
Group DI (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525–533
Patocka J, Nepovimova E, Wu W, Kuca K (2020) Digoxin: pharmacology and toxicology—a review. Environ Toxicol Pharmacol 79:103400
Article CAS PubMed Google Scholar
Abdel Jalil MH, Abdullah N, Alsous MM, Saleh M, Abu-Hammour K (2020) A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Br J Clin Pharmacol 86(7):1267–1280
Article CAS PubMed PubMed Central Google Scholar
Erdmann E (1976) Zur Bedeutung der Digoxin-Serumkonzentration und deren Beeinflussung
Oster ME, Kelleman M, McCracken C, Ohye RG, Mahle WT (2016) Association of digoxin with interstage mortality: results from the pediatric heart network single ventricle reconstruction trial public use dataset. J Am Heart Assoc 5(1):e002566
Article PubMed PubMed Central Google Scholar
Klausner RE, Parra D, Kohl K et al (2021) Impact of digoxin use on interstage outcomes of single ventricle heart disease (from a NPC-QIC registry analysis). Am J Cardiol 154:99–105
Article CAS PubMed Google Scholar
Moffett BS, Lupo PJ, Valdes SO, Miyake CY, Decker JA, Kim JJ (2015) Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young 25(6):1080–1085
Bowling CB, Pitt B, Ahmed MI et al (2010) Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ: Heart Fail 3(2):253–260
Schwinger R, Erdmann E (1992) Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 14(4):315–325
Jain S, Vaidyanathan B (2009) Digoxin in management of heart failure in children: should it be continued or relegated to the history books? Ann Pediatr Cardiol 2(2):149
Article PubMed PubMed Central Google Scholar
Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD (1984) Part I digitalis glycosides: mechanisms and manifestations of toxicity. Prog Cardiovasc Dis 26(5):413–458
Article CAS PubMed Google Scholar
Dasgupta S, Aly AM, Jain SK (2016) Junctional bradycardia as early sign of digoxin toxicity in a premature infant with congestive heart failure due to a left to right shunt. AJP Rep 6(1):e96
Rao MPR, Panduranga P, Sulaiman K, Al-Jufaili M (2013) Digoxin toxicity with normal digoxin and serum potassium levels: beware of magnesium, the hidden malefactor. J Emerg Med 45(2):e31–e34
Steiness E, Olesen K (1976) Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. Heart 38(2):167–172
Alsaied T, Baskar S, Fares M et al (2017) First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis. J Am Heart Assoc 6(12):e007164
Article PubMed PubMed Central Google Scholar
Osadchii OE (2010) Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. Fundam Clin Pharmacol 24(5):547–559
Article CAS PubMed Google Scholar
Rehman R, Hai O (2021) Digitalis toxicity. StatPearls Publishing, Tampa
Association AH (2005) Part 10.1: life-threatening electrolyte abnormalities. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.105.166563
Manini AF, Nelson LS, Hoffman RS (2011) Prognostic utility of serum potassium in chronic digoxin toxicity. Am J Cardiovasc Drugs 11(3):173–178
Article CAS PubMed PubMed Central Google Scholar
Thacker D, Sharma J (2007) Digoxin toxicity. Clin Pediatr 46(3):276–279
Hunter RW, Bailey MA (2019) Hyperkalemia: pathophysiology, risk factors and consequences. Nephrol Dial Transplant 34(3):2–11
El-Sarnagawy GN, Helal NE (2021) Predictive factors for recurrence of serious arrhythmias in patients with acute digoxin poisoning. Cardiovasc Toxicol 21(10):835–847
Article CAS PubMed Google Scholar
Gheorghiade M, Van Veldhuisen DJ, Colucci WS (2006) Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 113(21):2556–2564
Brown D, Spector R, Juhl R (1980) Drug interactions with digoxin. Drugs 20(3):198–206
Article CAS PubMed Google Scholar
Woudstra OI, Kuijpers JM, Meijboom FJ et al (2019) High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality. Eur Heart J Cardiovasc Pharmacother 5(4):216–225
Article PubMed PubMed Central Google Scholar
Musial A, Thomson JE (2020) A case to optimize medications in children with severe neurological impairment. JAMA Netw Open 3(12):e2029728–e2029728
Yukawa M, Yukawa E, Suematsu F et al (2011) Population pharmacokinetic investigation of digoxin in Japanese infants and young children. J Clin Pharmacol 51(6):857–863
Article CAS PubMed Google Scholar
Ehle M, Patel C, Giugliano RP (2011) Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. Crit Pathw Cardiol 10(2):93–98
Comments (0)